NCT00391820已完成2 期
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of TD-5108 for the Treatment of Chronic Constipation
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 360
- 试验地点
- 2
- 主要终点
- - Clinical response
研究概览
简要总结
Study 0038 compares the safety and effectiveness of an investigational drug, TD-5108 with placebo (a sugar pill) for the treatment of chronic constipation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 64 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Meet ROME III Criteria
排除标准
- •Constipation caused by:colonic etiology, pelvic floor dysfunction, metabolic disturbances, neurologic disturbances,concomitant medications affecting bowel function
- •Chronic treatment with anticholinergics, narcotic analgesics
- •Irritable Bowel Syndrome
结局指标
主要结局
- Clinical response
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)COPDNCT02040792Mylan Inc.355
已完成
2 期
Treatment of Cognitive Impairment in Men With Schizophrenia (MK5757-005)(COMPLETED)SchizophreniaNCT00848484Merck Sharp & Dohme LLC54
已完成
2 期
A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary DiseaseCOPDNCT02109172Mylan Inc.64
终止
2 期
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving HemodialysisUremic PruritusNCT01660243Toray Industries, Inc45
Unknown
2 期
Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)ObesityNCT00449202Manhattan Pharmaceuticals100